Literature DB >> 28179249

Penicillin skin testing as an antimicrobial stewardship initiative.

Bruce M Jones1, Christopher M Bland2.   

Abstract

PURPOSE: An initiative to determine the effects of penicillin skin testing (PST) from an antimicrobial stewardship perspective is described.
SUMMARY: Penicillin allergy is one of the most frequently reported allergies; however, only about 10% of self-reports of penicillin allergy are accurate. Incorrect penicillin allergies are therefore a significant barrier to antimicrobial stewardship, with important clinical and economic implications, including increased antimicrobial resistance, an increased overall cost of care, increased length of stay, and, ultimately, increased mortality. As part of its antimicrobial stewardship program, a community health system launched a PST initiative in order to optimize therapy, reduce adverse events acquisition costs, and minimize development of antibiotic resistance. The PST program involves the use of a standardized protocol for the assessment of hypersensitivity to penicillin in patients with suspected penicillin allergy. Among 36 patients who completed the PST protocol during an eight-month period, all had a negative result; in 27 of those patients, a conversion of antimicrobial therapy to a penicillin or cephalosporin was implemented as a direct result of PST.
CONCLUSION: In patients with a self-reported penicillin allergy, PST led to a reduction in the use of carbapenems, aztreonam, vancomycin, and other broad-spectrum agents within a health system. A decrease in drug costs was documented in a sample of patients switched to a penicillin or a cephalosporin after PST.
Copyright © 2017 by the American Society of Health-System Pharmacists, Inc. All rights reserved.

Entities:  

Keywords:  allergy; penicillin; pharmacist; skin test; stewardship

Mesh:

Substances:

Year:  2017        PMID: 28179249     DOI: 10.2146/ajhp160233

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  15 in total

1.  The Clinical and Financial Impact of a Pharmacist-Driven Penicillin Skin Testing Program on Antimicrobial Stewardship Practices.

Authors:  Stacy Harmon; Thomas Richardson; Heidi Simons; Summer Monforte; Shea Fanning; Kaitlyn Harrington
Journal:  Hosp Pharm       Date:  2018-12-13

Review 2.  The Current State of Antimicrobial Stewardship: Challenges, Successes, and Future Directions.

Authors:  Jennifer Emberger; Dan Tassone; Michael P Stevens; J Daniel Markley
Journal:  Curr Infect Dis Rep       Date:  2018-06-29       Impact factor: 3.725

3.  Penicillin Allergy Testing Is Cost-Saving: An Economic Evaluation Study.

Authors:  Bernardo Sousa-Pinto; Kimberly G Blumenthal; Eric Macy; Ana Margarida Pereira; Luís Filipe Azevedo; Luís Delgado; João Almeida Fonseca
Journal:  Clin Infect Dis       Date:  2021-03-15       Impact factor: 9.079

Review 4.  The challenge of de-labeling penicillin allergy.

Authors:  Cosby A Stone; Jason Trubiano; David T Coleman; Christine R F Rukasin; Elizabeth J Phillips
Journal:  Allergy       Date:  2019-05-26       Impact factor: 13.146

Review 5.  Skin Testing for Penicillin Allergy: a Review of the Literature.

Authors:  Tracy Zembles; Michelle Mitchell; Waleed Alqurashi; Mariana Castells; Elizabeth J Phillips; David Vyles
Journal:  Curr Allergy Asthma Rep       Date:  2021-03-18       Impact factor: 4.806

Review 6.  Acute care beta-lactam allergy pathways: approaches and outcomes.

Authors:  Anna R Wolfson; Emily M Huebner; Kimberly G Blumenthal
Journal:  Ann Allergy Asthma Immunol       Date:  2019-04-19       Impact factor: 6.347

7.  Review of Pharmacist Driven Penicillin Allergy Assessments and Skin Testing: A Multi-Center Case-Series.

Authors:  Hanna M Harper; Michael Sanchez
Journal:  Hosp Pharm       Date:  2021-09-16

8.  Evaluation of a Pharmacist-Led Penicillin Allergy Assessment Program and Allergy Delabeling in a Tertiary Care Hospital.

Authors:  Nicholas A Turner; Rebekah Wrenn; Christina Sarubbi; Renee Kleris; Patricia L Lugar; Christine Radojicic; Rebekah W Moehring; Deverick J Anderson
Journal:  JAMA Netw Open       Date:  2021-05-03

Review 9.  Allergic Reactions and Cross-Reactivity Potential with Beta-Lactamase Inhibitors.

Authors:  Kayla R Stover; Katie E Barber; Jamie L Wagner
Journal:  Pharmacy (Basel)       Date:  2019-06-28

Review 10.  Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  W J Heinz; D Buchheidt; M Christopeit; M von Lilienfeld-Toal; O A Cornely; H Einsele; M Karthaus; H Link; R Mahlberg; S Neumann; H Ostermann; O Penack; M Ruhnke; M Sandherr; X Schiel; J J Vehreschild; F Weissinger; G Maschmeyer
Journal:  Ann Hematol       Date:  2017-08-30       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.